Upgrade to SI Premium - Free Trial

Firefly Neuroscience (AIFF)

1.05 -0.01 (0.94%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (2/12/26 *Est.)

Latest Headlines

Form 4 FIREFLY NEUROSCIENCE, For: Sep 25 Filed by: Vnook Stella September 29, 2026 4:16 PM - SEC Filing Form 4 FIREFLY NEUROSCIENCE, For: Sep 25 Filed by: POSNER BRIAN M September 29, 2026 4:15 PM - SEC Filing Form 4 FIREFLY NEUROSCIENCE, For: Sep 25 Filed by: Menawat Arun Swarup September 29, 2026 4:15 PM - SEC Filing Firefly and NeuroSigma partner to expand pediatric ADHD treatment September 25, 2026 7:45 AM - StreetInsider Firefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access to First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD September 25, 2026 7:45 AM - StreetInsider Firefly Neuroscience to integrate EEG platform with Radial's clinic network September 17, 2026 7:51 AM - StreetInsider Firefly Neuroscience’s Evoke™ Platform Selected to Bring Objective Brain-Function Insights to Radial’s AI-Native Operating System for Brain Medicine September 17, 2026 7:50 AM - StreetInsider Form 3 FIREFLY NEUROSCIENCE, For: Sep 08 Filed by: Paz Jessica Lucia September 14, 2026 4:56 PM - SEC Filing Form 8-K FIREFLY NEUROSCIENCE, For: Sep 08 September 14, 2026 4:30 PM - SEC Filing Form 10-Q FIREFLY NEUROSCIENCE, For: Jun 30 August 11, 2026 6:01 AM - SEC Filing Form 8-K FIREFLY NEUROSCIENCE, For: Aug 05 August 7, 2026 4:31 PM - SEC Filing Firefly Neuroscience (NASDAQ: AIFF) Reports 291% Increase in TMS Center Customer Brain Scan Volumes August 5, 2026 7:45 AM - StreetInsider Firefly Neuroscience partners with Next Health on cognitive health platform July 28, 2026 7:50 AM - StreetInsider Firefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee’s Recommendation Backs Broader Access to Key Neuroprotective Peptides July 28, 2026 7:50 AM - StreetInsider Full Article List